Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals
ALNY | NASDAQ
Chart Builder DCF Calculator
$159.73
-$5.31 (-3.22%)
At close: Nov 16, 2026, 4:00 PM ET
$159.63
-$0.10 (-0.06%)
Pre-market: Nov 17, 2026, 4:01 AM ET

Alnylam Pharmaceuticals Insider Trading

Insider trading explained
90-Day Net Volume
$144.27K
90-Day Activity
2 Buys / 1 Sales
All-Time Net Volume
-$181.25M
Total Filings
1,004

Insider Trading Activity

Name Transaction Date Transaction Type Shares Price Value
Sigal Charles Elliott Director
Nov 10, 2026
P-Purchase Common Stock
1,600 152.25 $243,600
Schulman Amy W Director
Nov 9, 2026
P-Purchase Common Stock
1,910 156.82 $299,526
Supran Bryan EVP, CLO and Secretary
Oct 2, 2026
S-Sale Common Stock
1,758 226.88 $398,855
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.